Sickle Cell Disease Treatment Market 2025 to 2034
Sickle Cell Disease Treatment Market 2025 to 2034
Sickle Cell Disease Treatment Market (By Treatment: Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant; By End-use: Hospital, Specialty Clinics, Others; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 3.75 Bn
Forecast Year, 2034
USD 14.06 Bn
CAGR, 2025 - 2034
15.81%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global sickle cell disease treatment market, valued at over USD 3.75 billion in 2025, is projected to expand to approximately USD 14.06 billion by 2034, growing at a robust CAGR of 15.81%, driven by advances in therapies and rising patient awareness.
Sickle Cell Disease Treatment Market Size Analysis
Sickle Cell Disease Treatment Market Size By Treatment 2025 to 2034 (USD Billion)
| Treatment | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Blood Transfusion | 0.63 | 0.72 | 0.84 | 0.97 | 1.13 | 1.30 | 1.51 | 1.77 | 2.02 | 2.35 |
| Pharmacotherapy | 1.25 | 1.45 | 1.68 | 1.94 | 2.26 | 2.61 | 3.02 | 3.48 | 4.04 | 4.67 |
| Bone Marrow Transplant | 1.87 | 2.17 | 2.51 | 2.92 | 3.36 | 3.90 | 4.51 | 5.23 | 6.07 | 7.03 |
Sickle Cell Disease Treatment Market Size By End-use 2025 to 2034 (USD Billion)
| End-use | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | 0.63 | 0.73 | 0.84 | 0.98 | 1.12 | 1.32 | 1.51 | 1.76 | 2.02 | 2.37 |
| Specialty Clinics | 1.25 | 1.45 | 1.68 | 1.94 | 2.26 | 2.60 | 3.02 | 3.49 | 4.05 | 4.68 |
| Others | 1.87 | 2.16 | 2.51 | 2.91 | 3.37 | 3.89 | 4.52 | 5.23 | 6.06 | 7.01 |
Sickle Cell Disease Treatment Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.38 | 0.44 | 0.50 | 0.58 | 0.68 | 0.79 | 0.91 | 1.05 | 1.21 | 1.41 |
| LAMEA | 0.75 | 0.87 | 1.01 | 1.17 | 1.35 | 1.56 | 1.81 | 2.09 | 2.43 | 2.81 |
| Europe | 1.12 | 1.30 | 1.51 | 1.75 | 2.03 | 2.34 | 2.71 | 3.15 | 3.64 | 4.21 |
| Asia-Pacific | 1.50 | 1.73 | 2.01 | 2.33 | 2.69 | 3.12 | 3.62 | 4.19 | 4.85 | 5.62 |
Sickle Cell Disease Treatment Market Size to Hit USD 14.06 Billion by 2034
The global sickle cell disease treatment market size surpassed USD 3.75 billion in 2025 and is predicted to reach around USD 14.06 billion by 2034 with a registering a CAGR of 15.81%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
